UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses

Abstract : Colorectal cancer (CRC) is associated with metabolic and redox perturbation. The mitochondrial transporter uncoupling protein 2 (UCP2) controls cell proliferation in vitro through the modulation of cellular metabolism, but the underlying mechanism in tumors in vivo remains unexplored. Using murine intestinal cancer models and CRC patient samples, we find higher UCP2 protein levels in tumors compared to their non-tumoral counterparts. We reveal the tumor -suppressive role of UCP2 as its deletion enhances colon and small intestinal tumorigenesis in AOM/DSS-treated and Apc Min/+ mice, respectively, and correlates with poor survival in the latter model. Mechanistically, UCP2 loss increases levels of oxidized glutathione and proteins in tumors. UCP2 deficiency alters glycolytic pathways while promoting phospholipid synthesis, thereby limiting the availability of NADPH for buffering oxidative stress. We show that UCP2 loss renders colon cells more prone to malignant transformation through metabolic reprogramming and perturbation of redox homeosta-sis and could favor worse outcomes in CRC.
Document type :
Journal articles
Complete list of metadatas

Cited literature [72 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02309113
Contributor : Elizabeth Bernardo <>
Submitted on : Wednesday, October 9, 2019 - 8:20:42 AM
Last modification on : Friday, October 11, 2019 - 1:15:55 AM

File

Pecqueur2019Eq14.pdf
Publication funded by an institution

Identifiers

Citation

Esther Aguilar, Pauline Esteves, Tiphaine Sancerni, Veronique Lenoir, Thomas Aparicio, et al.. UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses. Cell Reports , Elsevier Inc, 2019, 28 (9), pp.2306-2316.e5. ⟨10.1016/j.celrep.2019.07.097⟩. ⟨inserm-02309113⟩

Share

Metrics

Record views

69

Files downloads

37